Exploring your options for Targeted Therapy for Cancer in India? Ginger Healthcare brings together a carefully chosen panel of reputed medical oncologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Targeted Therapy for Cancer. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Here are the most reputed hospitals in India for Targeted Therapy for Cancer. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Targeted therapy is a family of cancer treatments that attack the specific molecular features — mutated proteins, overactive signalling switches, or abnormal genes — that a particular tumour depends on to grow and spread. Unlike traditional chemotherapy, which damages all rapidly dividing cells, targeted drugs are designed to act on cancer-cell biology while leaving most normal cells relatively unaffected. Before treatment begins, the tumour is tested for specific biomarkers (gene mutations, protein expression, or gene fusions) to confirm that the cancer carries the molecular target the drug is designed to attack. Depending on the drug class, treatment may be taken as daily oral tablets at home or given as intravenous infusions at a hospital day-care unit every one to three weeks. In advanced cancers, targeted therapy is often continued for as long as the drug remains effective and tolerable, sometimes for many months or years.
Estimated cost: ~$500 – $1,000
Typical tests for this treatment: Biomarker / molecular profiling panel (NGS or targeted mutation testing — if not recently done), CBC with differential, Liver function tests (LFT), Kidney function tests (KFT / serum creatinine), 2D Echocardiogram (baseline cardiac function — required for HER2-directed or certain other agents), Thyroid function tests (TSH, T3, T4), Tumor marker panel (CEA, CA-125, AFP, HER2, or relevant marker), ECG. Done in India before treatment begins. Cost varies with case complexity.
Estimated cost in India: $4,500 – $9,000
That works out to roughly $500 – $1,500 per cycle across 6 cycles, plus a one-time pre-treatment work-up of about ~$500 – $1,000 (done once). Per-cycle figures are approximate — the headline range above covers the full course.
Treatment duration in India: ~4 months (6 cycles × 21 days, ~6 hospital visit days)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.